Nexa3D Delivers Breakthrough Economics for Additive Production with the Launch of XiP Pro Industrial 3D Printer

XiP Pro delivers highest daily throughput at the lowest operational costs for the production of industrial and medical device components, enabling onshoring and reshoring efforts with additive manufacturing Unlocks new production possibilities at speeds exponentially faster than nearest competitor; one XiP Pro can produce the same output as four of the next fastest industrial 3D … [Read more…]

Hildred Capital Management Completes Strategic Investment in AleraCare

Capital will be used by AleraCare to double clinical capacity over the next 24-months in an effort to provide even greater support to patients and providers NEW YORK–(BUSINESS WIRE)–Hildred Capital Management, (“Hildred” or the “Firm”) a healthcare-focused private equity firm that specializes in partnering with middle-market companies to help scale their businesses and create value, … [Read more…]

Kurin Receives 510k from the FDA with Indication to Reduce Blood Culture Contaminations

SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced today that the Food and Drug Administration has issued a 510(k) clearance for the Kurin product line. Kurin now has four 510(k) clearances from the FDA. The recent clearance says, in part, that Kurin reduces the frequency of blood … [Read more…]

Montecito Acquires Medical Property in Virginia

NASHVILLE, Tenn.–(BUSINESS WIRE)–Montecito Medical, a leading acquirer of medical office properties nationwide, has acquired a 209,000-square-foot medical office property in Roanoke, Virginia. The two-story building is tenanted by Carilion Children’s Clinic. “This is a remarkable medical real estate asset located in an attractive market area,” said Rus Gudnyy, Senior Vice President of Investments at Montecito … [Read more…]

From the Workplace to the Classroom, Walgreens Expands Commitment to Improving Mental Health and Wellbeing

Walgreens and Mental Health America collaborate to address youth mental health, bringing much-needed resources to local schools DEERFIELD, Ill.–(BUSINESS WIRE)–As part of Walgreens’ commitment to the health and wellbeing of the communities it serves, as well as to fostering a healthy and inclusive workplace, the company is expanding its efforts to meet the growing need … [Read more…]

Spesana Launches Advisory Board to Support Company Growth

Following a successful presentation and exhibit at this year’s Precision Medicine World Conference, a new advisory board is formed to support Spesana’s mission. MEMPHIS, Tenn.–(BUSINESS WIRE)–#digitalhealth–Spesana has announced the formation of the Spesana Advisory Board with appointments of experienced industry leaders across clinical sites, life science companies and diagnostic labs. The Advisory Board will collaborate … [Read more…]

Ecolab Delivers Very Strong First Quarter Operating Performance; Reported Diluted EPS $0.82; Adjusted Diluted EPS $0.88, +7%; Continue to Expect Further Performance Improvement Through 2023

    ST. PAUL, Minn.–(BUSINESS WIRE)–FIRST QUARTER HIGHLIGHTS: Reported sales $3.6 billion, +9% versus last year. Organic sales +13%, led by double-digit growth in the Institutional & Specialty, Industrial, and Other segment, and improved growth in the Healthcare & Life Sciences segment. Reported operating income +38%. Organic operating income growth accelerated to +19%, as continued … [Read more…]

Thermo Fisher Scientific to Present at BofA Securities 2023 Healthcare Conference on May 10th, 2023

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the BofA Securities 2023 Healthcare Conference on Wednesday, May 10, 2023 at 11:00 a.m. (EDT). You can access the webcast of the presentation via the Investors section … [Read more…]

Scorpion Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of STX-478, Its Mutant-Selective PI3Kα Inhibitor for the Treatment of Breast Cancer and Other Solid Tumors

 — STX-478 has a potential best-in-class profile and is Scorpion’s first program to enter clinical development — — Initial Phase 1 safety, pharmacokinetic and pharmacodynamic data and preliminary efficacy assessment expected in 2024 — BOSTON–(BUSINESS WIRE)–Scorpion Therapeutics, Inc. (“Scorpion”), a pioneering clinical-stage oncology company redefining the frontier of precision medicine through its Precision Oncology 2.0 … [Read more…]

Alto Neuroscience Announces CEO Amit Etkin, M.D., Ph.D., Named as an Entrepreneur Of The Year® 2023 Bay Area Award Finalist

Entrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futures LOS ALTOS, Calif.–(BUSINESS WIRE)–Alto Neuroscience today announced that Amit Etkin, M.D., Ph.D., founder and chief executive officer, was named an Entrepreneur Of The Year® 2023 Bay Area Award finalist. Now in its 37th year, Entrepreneur Of The Year by Ernst & Young (EY) … [Read more…]